Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID755 | SYFVELGTQPATQ | Apolipoprotein A-II | Plasma | 720.85 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID756 | SYFVELGTQPAT | Apolipoprotein A-II | Plasma | 656.82 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID757 | YFVELGTQPAT | Apolipoprotein A-II | Plasma | 613.31 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID758 | FVELGTQPATQ | Apolipoprotein A-II | Plasma | 595.8 | LC-MS | Ductal adenocarcinoma of the pancreas (DAP) | NA | 19795908 |
| CancerPDF_ID1996 | SPELQAEAK | Apolipoprotein A-II | Serum | 971.49238 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1997 | VKSPELQAEAK | Apolipoprotein A-II | Serum | 1198.65575 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1998 | SKEQLTPLI | Apolipoprotein A-II | Serum | 1027.59136 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1999 | VKSPELQAEA | Apolipoprotein A-II | Serum | 1070.56079 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID5012 | FQTVTDYGKDLME | Apolipoprotein A-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5013 | FQTVTDYGKDLMEKV | Apolipoprotein A-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5058 | FVELGTQPAT | Apolipoprotein A-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5059 | FVELGTQPATQ | Apolipoprotein A-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6468 | QAKEPCVESLV | Apolipoprotein A-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6469 | QAKEPCVESLVS | Apolipoprotein A-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6470 | QAKEPCVESLVSQ | Apolipoprotein A-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6471 | QAKEPCVESLVSQY | Apolipoprotein A-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6472 | QAKEPCVESLVSQYFQ | Apolipoprotein A-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6473 | QAKEPCVESLVSQYFQTVTDYGKDLMEKV | Apolipoprotein A-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7368 | TDYGKDLMEKV | Apolipoprotein A-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7675 | TVTDYGKDLMEKV | Apolipoprotein A-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7678 | TVVKQGFEPPSFVGW | Isoform 1 of Gelsolin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8022 | VTDYGKDLMEKV | Apolipoprotein A-II | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8842 | FQTVTDYGKDL | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8843 | FQTVTDYGKDLMEKV | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8844 | FQTVTDYGKDLMEKVKSPELQAEA | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8854 | FVELGTQPAT | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8855 | FVELGTQPATQ | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9143 | QAEAKSYFEK | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9144 | QAKEPCVESLVSQY | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9145 | QAKEPCVESLVSQYF | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9146 | QAKEPCVESLVSQYFQ | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9195 | QTVTDYGKDL | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9196 | QTVTDYGKDLMEKVK | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9207 | QYFQTVTDYGKDLME | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9278 | SYFVELGTQPAT | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9286 | TDYGKDLMEKV | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9345 | TVTDYGKDL | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9346 | TVTDYGKDLM | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9347 | TVTDYGKDLMEK | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9408 | VTDYGKDLME | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9409 | VTDYGKDLMEKV | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9433 | YFQTVTDYGKDLME | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9434 | YFVELGTQPAT | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9435 | YFVELGTQPATQ | Apolipoprotein A-II | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |